Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Epilepsies of early childhood are frequently resistant to therapy and often associated with cognitive and behavioural comorbidity. Aetiology focused precision medicine, notably gene-based therapies, may prevent seizures and comorbidities. Epidemiological data utilizing modern diagnostic techniques including whole genome sequencing and neuroimaging can inform diagnostic strategies and therapeutic trials. We present a 3-year, multicentre prospective cohort study, involving all children under 3 years of age in Scotland presenting with epilepsies. We used two independent sources for case identification: clinical reporting and EEG record review. Capture-recapture methodology was then used to improve the accuracy of incidence estimates. Socio-demographic and clinical details were obtained at presentation, and 24 months later. Children were extensively investigated for aetiology. Whole genome sequencing was offered for all patients with drug-resistant epilepsy for whom no aetiology could yet be identified. Multivariate logistic regression modelling was used to determine associations between clinical features, aetiology, and outcome. Three hundred and ninety children were recruited over 3 years. The adjusted incidence of epilepsies presenting in the first 3 years of life was 239 per 100 000 live births [95% confidence interval (CI) 216–263]. There was a socio-economic gradient to incidence, with a significantly higher incidence in the most deprived quintile (301 per 100 000 live births, 95% CI 251–357) compared with the least deprived quintile (182 per 100 000 live births, 95% CI 139–233), χ2 odds ratio = 1.7 (95% CI 1.3–2.2). The relationship between deprivation and incidence was only observed in the group without identified aetiology, suggesting that populations living in higher deprivation areas have greater multifactorial risk for epilepsy. Aetiology was determined in 54% of children, and epilepsy syndrome was classified in 54%. Thirty-one per cent had an identified genetic cause for their epilepsy. We present novel data on the aetiological spectrum of the most commonly presenting epilepsies of early childhood. Twenty-four months after presentation, 36% of children had drug-resistant epilepsy (DRE), and 49% had global developmental delay (GDD). Identification of an aetiology was the strongest determinant of both DRE and GDD. Aetiology was determined in 82% of those with DRE, and 75% of those with GDD. In young children with epilepsy, genetic testing should be prioritized as it has the highest yield of any investigation and is most likely to inform precision therapy and prognosis. Epilepsies in early childhood are 30% more common than previously reported. Epilepsies of undetermined aetiology present more frequently in deprived communities. This likely reflects increased multifactorial risk within these populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common DEE syndrome is Infantile Epileptic Spasms Syndrome (IESS) with an incidence of 30.7 in 100,000 individuals (95% CI 22.9-40.2) to 48.9 in 100,000 individuals (95% CI 37.0-64.7);~27% of IESS have a structural aetiology 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Incidence estimates have been reported for many DEE syndromes; however, around one-third of patients cannot be classified as having a specific syndrome 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In comparison, the estimated incidence of all epilepsies presenting under 3 years was 239 in 100,000 (95% CI 216-263) in a prospective study in Scotland, UK, with DEEs accounting for 86.1 in 100,000 (95% CI 72.7-101.3)children 9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Self-citationKwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073 · cited 1×
“On a population level, the highest age-specific incidences of 460 per 100 000 are observed in children under 5 years of age and in adults over 65 years of age.(9) A significant proportion (35%) of children presenting with epilepsies in the first 3 years of life develop drugresistant seizures.”
BackgroundTrial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711 · cited 1×
“Precise clinical classification of epilepsy syndrome, and identification of a genetic aetiology, helps guide therapeutic strategy, exemplified by randomized controlled trials in Lennox-Gastaut syndrome,(4,5) and Dravet syndrome.(6,7) For the individually rare but severe epilepsies caused by large effect mutations in a…”
BackgroundEffect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015
Self-citationThiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Self-citationState of the Art Review: Poverty and the Developing Brain
Johnson, S. B., Riis, J. L., & Noble, K. G. (2016) · Pediatrics · doi:10.1542/peds.2015-3075 · Cited by 624
Cited by
Items 101–200 of 308
Developmental and epileptic encephalopathies
Gill, R. E., Ludwig, N. N., & Stafstrom, C. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00009-2 · Cited by 5
Hadjinicolaou, A., Abath, C. B., Singh, A., Donatelli, S., Salussolia, C. L., Cohen, A. L., He, J., Gupta, N., Merchant, S., Zhang, B., et al. (2024) · Epilepsia · doi:10.1111/epi.17900 · Cited by 5
Donnellan, E. P., Kehoe, C. M., Moran, A., Chollatain, M. N., Hynes, Y., Hennessy, M. J., Reade, E., & Allen, N. M. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109804 · Cited by 5
“[17], which evaluated all children under the age 3 years in Scotland, reported classification of aetiology in 54 % of cases (no presumed genetic aetiology included), while identifying aetiology as a key determinant of drug resistant epilepsy and global delay.”
BackgroundMethodAbend, N. S., Wusthoff, C. J., Jensen, F. E., Inder, T. E., & Volpe, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10513-5.00015-2 · Cited by 5
The dysregulation and regulatory mechanism of long non-coding RNA LBX2-AS1 in children with epilepsy
Li, Q., & Li, N. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-02045-0 · Cited by 4
“Epilepsy is a long-lasting neurological condition distinguished by recurring seizures that result from irregular electrical activity in the brain [1].”
Circulating microRNAs as potential biomarkers in pediatric epilepsy: a pilot study
Rzepka-Migut, B., Kruszniewska‐Rajs, C., Bugowska, M., Krzempek, M., Gola, J. M., Striano, P., & Paprocka, J. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110631 · Cited by 4
“Genetic epilepsies were the largest etiological group[17].”
Xie, Y., Shao, Y., Li, Y., Liu, H. Y., Zhang, B., Wu, J., Jiang, C., & Wu, H. (2025) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2025.2581660 · Cited by 4
Qiu, Y., Song, B., Xie, M., Tao, Y., Yin, Z., Wang, M., Ma, C., Chen, Z., & Wang, Z. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1397430 · Cited by 4
SCN8A self ‐limited infantile epilepsy: Does epilepsy resolve?
Young, E., Harris, R. V., Lieffering, N., de Valles‐Ibáñez, G., Nyaga, D. M., Bennett, M. F., Hildebrand, M. S., Scheffer, I. E., & Sadleir, L. G. (2024) · Epilepsia · doi:10.1111/epi.18016 · Cited by 4
Effect of quercetin against pilocarpine-induced epilepsy in mice
Abdulsahib, W. K., & Al-Radeef, M. Y. (2024) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_496_23 · Cited by 4
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population
Daniłowska, K., Picheta, N., Żyła, D., Piekarz, J., Zych, K., & Gil-Kulik, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123567 · Cited by 4
“Epilepsy is encountered in 4–10% of the pediatric population [6,7].”
BackgroundInfantile epileptic spasms syndrome: When spasms come out of the blue
Conti, M., Matricardi, S., Piscitello, L. M., Auconi, M., Cursio, I., Terracciano, A., Vigevano, F., Specchio, N., Marini, C., & Fusco, L. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110180 · Cited by 4
Avital, D., Noyman, I., Bistritzer, J., Goldbart, A. D., Hazan, G., Langman, Y., Ziv, O., Hazan, I., & Golan‐Tripto, I. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06105-9 · Cited by 4
“In high-income countries, the prevalence of epilepsy in children ranges from 0.5 to 1%, while Israel reports a prevalence of 0.6% under the age of 18 [3, 4].”
InfluentialKanmaz, S., Yılmaz, S., Ölçülü, C. B., Toprak, D. E., İnce, T., Yılmaz, Ö., Ataş, Y., Şen, G., Şimşek, E., Serin, H. M., et al. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.05.018 · Cited by 4
The multidimensional impact of Dravet syndrome on caregivers: A comprehensive review
Poprelka, K., Fasilis, T., Patrikelis, P., Ntinopoulou, E., Verentzioti, A., Stefanatou, M., Alexoudi, A., Stavrinou, L. C., Korfias, S. I., & Gatzonis, S. D. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110376 · Cited by 3
Huang, K., Xie, Y., Ran, H., Hu, J., He, Y., Xu, G., Chen, G., Yu, Q., Li, X., Liu, J., et al. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111403 · Cited by 3
“Epilepsy is one of the most common chronic neurological conditions (Symonds et al., 2021).”
Chen, Y., Zeng, C., Luo, C., Huang, B., Chen, S., Deng, W., Lan, S., & Li, C. (2025) · Seizure · doi:10.1016/j.seizure.2025.10.022 · Cited by 3
Dorris, L., Aras, L. M., Danse, M., Benzler, N., Camus, C. H.-L., Darra, F., Fons, C., Robinson, R. A., Holert, N., Afonso, P., et al. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110809 · Cited by 3
Self-citationKhuhro, Z., Smith, A., & Tobias, J. D. (2026) · Journal of Pediatric Neurosciences · doi:10.4103/jpn.jpn_135_25 · Cited by 3
Trabacca, A., Rinaldis, M. D., Oliva, M. C., Notaristefano, I., Gallo, I., Ferrante, C., & Fanizza, I. (2026) · Genes · doi:10.3390/genes17030275 · Cited by 3
Schubert‐Bast, S., Kaur, M., Joeres, L., Foskett, N., Roebling, R., & Strzelczyk, A. (2023) · Seizure · doi:10.1016/j.seizure.2023.09.022 · Cited by 3
“The huge variability in the data sources was observed among the included studies; studies used different data sources, i.e. tertiary data [11,6], hospital data [3,20,22, 30,33,38], registry data [4,24,25,27,29,31,35], claims database [26,34, 39,40], survey [21,32], primary care [28,37], primary…”
Akiyama, L. F., & Saneto, R. P. (2023) · Pediatric Annals · doi:10.3928/19382359-20230829-01 · Cited by 3
Passos, A. C. V., de Azevedo, M. E. C., & Mendes, C. M. D. M. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n6-035 · Cited by 3
Wang, X., Huang, Y., Chen, L., Mai, J., Fang, D., Mo, T., Qi, X., & Zeng, H. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.12.009 · Cited by 3
Impact of and research priorities in early onset epilepsy: An investigation of parental concerns
Lindsay, N., Martin, J., Adegboye, D., Absoud, M., Charman, T., & Tye, C. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109794 · Cited by 3
“The increased likelihood of cognitive and behavioural comorbidity, and of early mortality presents early onset epilepsy as a serious medical concern [4].”
BackgroundKanmaz, S., Tekgül, H., Kayılıoğlu, H., Ataş, Y., Kart, P. Ö., Yıldız, N., Gümüş, H., Aydin, K., Kanmaz, S., Kayilioglu, H., et al. (2024) · Seizure · doi:10.1016/j.seizure.2024.09.021 · Cited by 3
Umeda, M., Okanishi, T., Kobayashi, S., Itamura, S., Hirayama, Y., Matsumura, W., Arai, Y., Fujimoto, A., & Maegaki, Y. (2025) · Epilepsia · doi:10.1111/epi.18347 · Cited by 4
Jonsson, H., de Sena, S., Linnankivi, T., Gaily, E. K., & Stjerna, S. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110397 · Cited by 4
“Structural etiology commonly links to developmental delay [2], while genetic etiologies vary in outcome depending on the specific gene variant and syndromic presentation [3,27,28].”
Yang, Y., Kang, J., Zhang, Y., Cai, Y., Fang, Q., Huang, Y., Huang, C., Chen, Q., He, Y., & Lin, F. (2025) · Brain and Development · doi:10.1016/j.braindev.2025.104357 · Cited by 3
Gupta, C., Narang, B., Thenral, S. G., Sharma, R., Chatterjee, S., Ramprasad, V. L., Murugan, S., Goyal, P., Bansal, R. K., & Jain, V. (2025) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16469 · Cited by 3
“3,12 On multivariate logistic regression, our data reiterate what is already known 3,12 that, irrespective of the underlying aetiology, in children with a younger age at seizure onset and those with associated neurodevelopmental issues, a guarded prognosis should be given to families for long-term…”
InfluentialFeria-Romero, I. A., Reyes-Cuayahuitl, A., Sosa-Maldonado, J., Montes-Aparicio, A. V., Mares, D. R., Pérez‐Pérez, D., Grijalva, I., & Orozco-Suárez, S. A. (2023) · Gene · doi:10.1016/j.gene.2023.147565 · Cited by 3
WONOEP appraisal: Modeling early onset epilepsies
Meulemeester, A. D., Reid, C. A., Auvin, S., Carlen, P. L., Cole, A. J., Szlendak, R., Sapia, R. D., Moshé, S. L., Sankar, R., O'Brien, T. J., et al. (2024) · Epilepsia · doi:10.1111/epi.18063 · Cited by 3
Electroclinical Syndromes: Infantile Onset
Nickels, K. C., & Wirrell, E. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00092-5 · Cited by 3
Thangarajan, R., & Bakthavatchalam, P. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-7327-7_9 · Cited by 3
Gan, Y., Yang, X., Li, T., Han, Z., Cheng, L., Xie, L., & Jiang, L. (2025) · Biomedicines · doi:10.3390/biomedicines13020269 · Cited by 2
“In infants and young children, seizures represent one of the most common neurological emergencies, with approximately 5% of children experiencing such episodes [5,7].”
Smal, N., Millevert, C., Wachter, M. D., Vriendt, E. D., Eddafir, Z., Schoonjans, A., Bayat, A., Møller, R. S., Mei, D., Balestrini, S., et al. (2025) · Epilepsia · doi:10.1111/epi.18279 · Cited by 2
Sun, N., Wang, Y., Huang, S., Yang, L., & Li, D. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1509660 · Cited by 2
Ketogenic diet alleviates neuronal ferroptosis in epilepsy via HDAC4/TFRC signalling
Wen, A., Xing, M., Fan, W., Zheng, K., & Xu, X. (2025) · Archives of Medical Science · doi:10.5114/aoms/207708 · Cited by 2
“The progression of epilepsy promotes the increase in lipid peroxidation, ischaemia, inflammation, and oedema, which are the key factors for the loss of hippocampal neurons, and hippocampal sclerosis [1, 5].”
What is the right choice? Is the answer sodium channel blockers?
Yanartaş, M. S., Donbaloğlu, F., Genç, Ş., Sait, A., Köken, Ö. Y., & Haspolat, Ş. (2025) · Epileptic Disorders · doi:10.1002/epd2.70063 · Cited by 2
Neurocognitive outcomes of ADHD as a comorbidity in pediatric epilepsy: a systematic review
Leal, L. Z., KEHL, I., Polesello, N. D., de Souza, Y. A., Schmitz, C. H., Viola, T. W., & Nunes, M. L. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110852 · Cited by 2
Lilles, S., Heidmets, K., Oja, K. T., Reinson, K., Roht, L., Pajusalu, S., Wojcik, M. H., Õunap, K., & Talvik, I. (2026) · Pediatric Reports · doi:10.3390/pediatric18010008 · Cited by 2
Daida, A., Matsuura, R., Hamano, S., Zhang, Y., Oba, A., Horita, H., Hirata, Y., Koichihara, R., Roychowdhury, V., Nariai, H., et al. (2026) · Epilepsia · doi:10.1002/epi.70130 · Cited by 2
“To minimize such effects, we included only patients with IESS of unknown etiology, who are known to have better cognitive outcomes than those with other etiologies, 5,22,23 assuming that the TC network before IESS onset is relatively intact.”
Wang, Z., Huang, J., Chen, M., Li, Q., & Wu, X. (2026) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2025-003970 · Cited by 2
Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches
Saad, A. K., & Akawi, N. A. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08936-2 · Cited by 2
“However, 70 to 80% of epilepsy cases are not attributed to these factors and are termed genetic or idio - pathic epilepsy [ 12 , 14].”
Datta, S., Negi, S., Madaan, P., Viswanathan, S., Valente, K. D. R., Wilmshurst, J. M., Sankhyan, N., & Sahu, J. K. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.04.006 · Cited by 2
Melo, M. M. C., de Abreu, L. B., & Pereira, L. R. L. (2026) · Seizure · doi:10.1016/j.seizure.2026.05.004 · Cited by 2
Halman, A., Freeman, J. L., Fahey, M. C., Chenhall, R. D., & Perkins, D. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.111095 · Cited by 2
Surabhi, P., Fasaludeen, A., Jose, M., Manisha, K. Y., Koshy, K. G., Sundaram, S., Banerjee, M., Safvan, K., Radhakrishnan, A., & Menon, R. (2026) · Seizure · doi:10.1016/j.seizure.2026.05.029 · Cited by 2
Auvin, S., Guillo, S., Rycke, Y. D., Tran, D., & Tubach, F. (2024) · Epilepsia · doi:10.1111/epi.17906 · Cited by 2
“2,17,18 CLB is the most commonly benzodiazepine prescribed in France, and the use of CNZ and CLB decreasing over the study period differs from the recent Norwegian report where CNZ was more commonly prescribed than CLB.”
ResultZhu, Y., Wang, G., Wang, K., Sun, M., Zhao, L., Zeng, Y., Yan, C., Ji, Y., Hou, Y., Li, Z., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00828 · Cited by 2
Udani, V. P. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110645 · Cited by 2
Zebrafish-based assessment of luteolin’s potential in modulating seizure responses
Schneider, S. E., Pedroso, J., Lima‐Rezende, C. A., Mazon, S. C., dos Santos, A. E., Aguiar, G. P. S., Lanza, M., Hort, M. A., de Oliveira, J. V., Piato, Â., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1656301 · Cited by 2
Zinger, J. W., Rietdijk, W. J. R., van den Berg, S., Neuteboom, R. F., Ruijgrok, E. J., van der Louw, E. J. T. M., & Nijstad, A. L. (2025) · Seizure · doi:10.1016/j.seizure.2025.10.013 · Cited by 2
Distinct contribution of monocarboxylate transporter 2 to infantile epileptic spasms syndrome
Liu, J., Lin, H., Wang, D., Chen, N., & Li, T. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111359 · Cited by 1
Wu, C., Zheng, J., Pan, Y., Tao, R., Zhong, Z., Qian, C., Liang, H., & Wu, H. (2024) · Personalized Medicine · doi:10.1080/17410541.2024.2441655 · Cited by 1
Shimomura, H., Taniguchi, N., Fujino, T., Tokunaga, S., Taniguchi, Y., Nishioka, T., Tokuda, N., Okuda, M., Shima, M., Takeshima, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-81913-x · Cited by 1
Brulé, S., Dozières‐Puyravel, B., Nasser, H., Elmaleh, M., Mauvais, F., & Auvin, S. (2025) · Epilepsia · doi:10.1111/epi.18383 · Cited by 1
“3,22 In our study, seven patients met the diagnostic criteria for an ILAE syndrome comprising myoclonic seizures, namely MEI or PME.”
Frequency of Anxiety and Depression in Patients of Epilepsy
Jalal, O., Ahmad, U., Kakar, M. S., Muhammad, A., Fatima, M., & Hammad, S. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs20231710150 · Cited by 1
Semal, B., Neuens, S., Vilain, C. N., Laet, C. D., Leurquin‐Sterk, G., Sculier, C., Baijot, S., & Aeby, A. (2025) · Neuropediatrics · doi:10.1055/a-2627-2097 · Cited by 1
Physical activity in children with epilepsy in China: A mixed-method study
Zhao, J., Li, S., Zhang, N., Zeng, J., Xie, Y., Fan, M., Xia, Q., & Hong, S. (2025) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2025.06.042 · Cited by 1
Huang, Y., Xu, S., Wang, X., Mo, T., Hu, Y., Meng, X., Fang, D., Zou, D., Chen, L., & Zeng, H. (2025) · Epilepsia · doi:10.1111/epi.18620 · Cited by 1
“4,14 Currently, few studies focus on the brain morphology of these patients.”
Zhao, Y., & Wu, Y. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08899-1 · Cited by 1
“Epilepsy has a high incidence in early childhood (Symonds et al., 2021).”
Global burden of epilepsy attributable to neonatal disorders in children from 1990 to 2021
Zhong, S., Lian, Y., Yi, H., Jia, K., Zhang, N., Kwan, P., Yang, Y., & Tian, X. (2026) · iScience · doi:10.1016/j.isci.2026.115296 · Cited by 1
“19,20 The prevalence and YLDs of epilepsy have increased in this age group.”
Genetic spectrum and risk factor analysis for drug-resistant of early-onset epilepsy
Han, M., Ju, X., Chen, X., Zou, P., Wu, D., Shi, W., Gu, M., & Yuan, T. (2026) · Translational Pediatrics · doi:10.21037/tp-2025-aw-826 · Cited by 1
“Pediatric populations, particularly those with early-life seizure onset, exhibit disproportionately high rates of therapeutic resistance (17,18) , often accompanied by severe cognitive and behavioral comorbidities (19) .”
Banerjee, S., Earl, C. W., Robson, S. C., Szyszka, P., & Beck, C. W. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1777738 · Cited by 1
“Although individual DEE syndromes are rare, their collective incidence approaches 1 in 590 children, making them a major cause of early-life neurological disability (3, 6).”
Lilles, S., Heidmets, K., Oja, K. T., Reinson, K., Roht, L., Pajusalu, S., Wojcik, M. H., Õunap, K., & Talvik, I. (2026) · Neurology International · doi:10.3390/neurolint18050076 · Cited by 1
“Early-onset epilepsy is often caused by genetic disorders and structural abnormalities, such as congenital brain malformations and perinatal brain injuries [14].”
InfluentialŠabová, D., Švecová, L., Mikloskova, M., & Kolníková, M. (2026) · Epileptic Disorders · doi:10.1002/epd2.70428 · Cited by 1
Behavioral comorbidities of early-life seizures: Insights from developmental studies in rats
Grígelová, A., Mikulecká, A., & Kubová, H. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110307 · Cited by 1
“Within the first three years of life incidence of epilepsies 239 per 100,000 live births has been reported [1].”
The impact of hydrocephalus on pediatric epilepsy: insights from a single-center investigation
Albaradie, R., Amena, A., & Bashir, S. (2025) · Acta Epileptologica · doi:10.1186/s42494-025-00211-9 · Cited by 1
Neonatale Entwicklungs- und epileptische Enzephalopathien
Datta, A. (2025) · Clinical Epileptology · doi:10.1007/s10309-025-00772-2 · Cited by 1
Diagnosis and Treatment of Epilepsy Syndromes
Yan, Y., Wang, Y., Xiao, F., Wang, X., Zhang, H., Hu, Y., Luo, R., Jiang, L., Wu, Y., Liu, X., et al. (2025) · Springer eBooks · doi:10.1007/978-981-96-8520-2_5 · Cited by 1
Management of Diabetes Mellitus (DM) and it’s Complications: A Literature Review
Fakhri, F. P. K., Kurniasari, N., & Anisah, H. (2025) · Magna Scientia Advanced Research and Reviews · doi:10.30574/msarr.2025.14.2.0103 · Cited by 1
Clinical advances in investigational epilepsy treatments
Јаnkovic, S. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2574992 · Cited by 1
“Developmental epilepsies, which are part of various genetically determined syndromes, present a special problem in treatment because they often have polymorphic convulsions that can evolve, which requires therapeutic action on multiple disorders at the cellular and molecular level [4].”
Suleiman, S., Hasan, J., Jarjees, K. I., & Haji, A. (2025) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2025.l963 · Cited by 1
Treatment considerations for the management of neonatal onset seizures
Burdine, J., Capino, A. C., Harlow, M., Mitchell-Vansteele, A., & Cokley, J. A. (2025) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/jppt-24-00037 · Cited by 1
Between seizures and schooling: qualitative insights into the experiences of children with epilepsy
KILIÇ, S., Karakul, A., & Düzkaya, D. S. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110869 · Cited by 1
Abdygalyk, B., Rabandiyarov, M., Lepessova, M., Koshkimbayeva, G., Zharkinbekova, N., Tekebayeva, L., Zhailganov, A., Issabekova, A., Myrzaliyeva, B., Tulendiyeva, A., et al. (2025) · Medicina · doi:10.3390/medicina61122223 · Cited by 1
Zhao, F., Hu, W., Zhang, W., Lu, Y., Li, J., & Zhang, H. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1701141 · Cited by 1
Wan, L., Lin, N., Wang, W., Liang, Z., Dong, Y., He, H., Chen, J., Fan, Y., Liu, T., Wang, H., et al. (2026) · Epilepsia · doi:10.1002/epi.70194 · Cited by 1
Zhang, L., Liu, W., Xue, Y., Wang, L., Gong, C., She, Z., & Li, H. (2026) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2026.03 · Cited by 1
Neurodevelopmental and psychiatric comorbidities in children with epilepsy
Hafström, M., Mehlig, K., Olssøn, I., Reilly, C. J., Zelano, J., & Hermansson, J. (2026) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.70302 · Cited by 1
Ethical Frameworks to Support Parents With a Learning Disability in Social Care and Social Work
Carey, M., & Constance, L. (2026) · Journal of Social Work · doi:10.1177/14680173261441997 · Cited by 1
Li, Y., Lee, D., Peng, C., Stromberg, J. E. S., Siskind, C. E., Meador, K. J., Le, S. T., & Razavi, B. (2026) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200624 · Cited by 1
Keenan, N. F., Stanley, J., Stairmand, J., Ali, S. S., Andersen, E., Davis, S. L., & Sadleir, L. G. (2026) · Neurology · doi:10.1212/wnl.0000000000218688 · Cited by 1
Novel copy number variations and phenotypes of infantile epileptic spasms syndrome
Cheng, M., Bai, L., Yang, Y., Liu, W., Niu, X., Chen, Y., Tan, Q., Yang, X., Wu, Q., Zhao, H., et al. (2024) · Clinical Genetics · doi:10.1111/cge.14520 · Cited by 1
Kyrylova, L. H., Miroshnikov, О. О., Yuzva, О. О., Badiuk, V. M., Dolenko, O. O., & Bondarenko, Y. M. (2024) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.20.2.2024.1056 · Cited by 2
Electroclinical Features of Infantile Epileptic Spasms Syndrome
Erdemir, G., & Moosa, A. N. V. (2024) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_445_24 · Cited by 1
Balancing efficacy and safety: The dual impact of antiseizure medications on the developing brain
Oliveira, M. S., Fernandes, R. A., Pinto, L. S. F. D. S., Moreira, F. A., de Castro, O. W., & Santos, V. R. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110400 · Cited by 1
Paediatric Epilepsy: A Comprehensive Overview of Diagnosis, Treatment and Management
Sireesha, V., Nikshitha, M., Nikitha, S., Ramya, K., & Rao, T. R. (2025) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.20250335 · Cited by 1
General mental ability (Spearman's g) in Juvenile Myoclonic Epilepsy
Struck, A. F., Garcia‐Ramos, C., Prabhakaran, V., Nair, V. A., Adluru, A., Almane, D. N., Adluru, N., Jones, J. E., & Hermann, B. P. (2025) · Epilepsia Open · doi:10.1002/epi4.70111 · Cited by 1
“…also serve as a “window to disadvantage” given the increasing reports of associations of epilepsy incidence and prevalence and health care usage, 57–60 neuroimaging abnormalities, 41 and problematic academic and behavioral problems and prospective cognitive trajectories in the face of greater…”
Precision in child neurology: Networks, systems, and technology
Zuberi, S. M. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15222 · Cited by 1
Self-citationVossler, D. G. (2023) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597231203079 · Cited by 1
Farmacoterapia da epilepsia em pediatria
Faustino, M. F. P. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Educational strategies used in paediatric epilepsy : a descriptive literature review
Samokhin, L. (2023) · Theseus (Ammattikorkeakoulujen) · Cited by 1
Choi, S. A. (2023) · Epilia Epilepsy and Community · doi:10.35615/epilia.2023.00389
Heterogeneity in INF-γ Levels Among Children with Different Types of Epilepsy
Gakharia, T., Bakhtadze, S., Khachapuridze, N., & Kapanadze, N. (2023) · Georgian Biomedical News · doi:10.52340/gbmn.2023.01.01.35
“Regrettably, a higher incidence is reported in underdeveloped countries.(2) The pathogenesis of epilepsy involves complex mechanisms that are still not fully understood.”
BackgroundUnravelling key pathways in childhood ataxia to guide diagnosis and treatment
Brunklaus, A. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.07.001
Self-citationBaumgartner, C., Asamoah-Akwonu, L., Koren, J. P., Lang, C., & Pirker, S. (2023) · Klinische Neurophysiologie · doi:10.1055/a-2132-9596
Rare epilepsy syndromes: understanding treatment goals and management challenges
Kerr, N. (2023) · Learning Disability Practice · doi:10.7748/ldp.2023.e2230
Metadata
- Authors
- Symonds, J. D., Elliott, K. S., Shetty, J., Armstrong, M., Brunklaus, A., Cutcutache, I., Diver, L. A., Dorris, L., Gardiner, S., Jollands, A., Joss, S., Kirkpatrick, M., McLellan, A., MacLeod, S., O’Regan, M., Page, M., Pilley, E., Pilz, D. T., Stephen, E., Stewart, K., Ashrafian, H., Knight, J. C., & Zuberi, S. M.
- Affiliations
- Royal Hospital for Children (GB)
- Centre for Human Genetics (GB)
- UCB Pharma (Belgium) (BE)
- UCB Pharma (United Kingdom) (GB)
- Queen Elizabeth University Hospital (GB)
- NHS Tayside (GB)
- University of Dundee (GB)
- Royal Aberdeen Children's Hospital (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-01
- Volume
- 144
- Issue
- 9
- Pages
- 2879-2891
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC8557326
- OpenAlex
- W3168961767
- Cited by
- 269
- References
- 44
- Citations by year
- 2026: 66 · 2025: 72 · 2024: 64 · 2023: 49 · 2022: 17
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Dravet Syndrome UK
- Epilepsy Research UK
- Glasgow Children’s Hospital Charity
- UCB Pharma
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- early childhood epilepsy, epilepsy incidence, socioeconomic deprivation, epilepsy etiology, drug-resistant epilepsy, global developmental delay, epilepsy syndromes, genetic epilepsy, whole genome sequencing, mark-recapture, epilepsy classification, Scotland, children under 3 years, gene therapy, precision medicine, neuroimaging, prospective cohort
- MeSH terms
- Drug Resistant Epilepsy, Child, Preschool, Epilepsy, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Retrospective Studies, Scotland, Socioeconomic Factors, Cohort Studies, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.